Can octreotide be added to parenteral nutrition solutions? Point-counterpoint: Yes, octreotide can be added to parenteral nutrition solutions

Nutrition in Clinical Practice

Volumn 13, Issue 2, 1998, Pages 84-87

  Seidner, Douglas L ^a   Speerhas, Rex ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007788259     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lamberts SWJ, van der Lely AJ, de Herder WW, etal. Octreotide. N Engl J Med 1996;334:246-54.
2. Harris AG. Octreotide in the treatment of disorders of the gastrointestinal tract. Drug Invest 1992;4:1-54.
3. Martineau P, Shwed JA, Denis R. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 1996;172:386-95.
4. Sancho JJ, di Costanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82:638-41.
5. Nubiola-Calonge, Sancho J, Segura M, et al. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987;ii:672-3.
6. Scott NA, Finnegan S, Irving MH. Octreotide and postoperative enterocutaneous fistulae: A controlled prospective study. Acta Gastroenterologica Belgica 1993;56:266-70.
7. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas: A multicenter trial. Arch Surg 1992;127:97-100.
8. Ippoliti C, Champlin R, Bugazia N, et al. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies. J Clin Oncol 1997;15:3350-4.
9. Morton AJP, Durrant STS. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation. Clin Transplant 1995;9:205-8.
10. Ely P, Dunitz J, Rogosheske J, et al. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease. Am J Med 1991;90:707-10.
11. O'Keefe SJD, Peterson ME, Fleming CR. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN 1994;18:26-36.
12. O'Keefe SJD, Haymond MW, Bennet WM, et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994;107:379-88.
13. Ritchie D J, Holstad SG, Westrich TJ, et al. Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm 1991;48:2172-5.
14. Hsu VD, Rosen GH, Leslie J. In vitro evaluation of stability of octreotide and compatibility of insulin in parenteral nutrient mixtures [Abstr]. American Society of Hospital Pharmacists Annual Meeting 1991;48:33E.